How to Run a LinkedIn Outreach Campaign for AI Leaders in Healthcare & Life Sciences (2026)

Origami has a built-in LinkedIn sequencer that lets you find, enrich, and sequence an entire campaign from a single platform. If you’ve already built a list of AI leaders in healthcare and life sciences (or are about to), this guide walks you through the exact campaign that turns those names into conversations. No exporting CSVs, no syncing tools—just one workflow from prompt to reply.

This is the companion piece to the list-building guide: how to build a list of AI Leaders in Healthcare & Life Sciences. Read that first if you don’t have a prospect list yet. Here, we’re assuming the list is built; now we’re going to refine it, write a sequence that sounds human, and send it directly inside Origami.

---

Step 1: Build & Refine the List (If You Already Did This, Jump to Step 2)

Origami builds a prospect list from a single plain-English prompt. If you followed the parent guide, you already ran something like:

“Find AI Directors, VPs of AI, Heads of Data Science, and Chief AI Officers at US-based healthcare providers, pharma companies, biotech firms, and medical device manufacturers with more than 200 employees. Include verified email addresses, direct dials, and LinkedIn profiles.”

Within minutes, Origami’s AI agent searched the live web, chained data sources, enriched contacts, and returned a table of names, titles, emails, phone numbers, company details, and a qualification score. The free plan gives you 1,000 credits (no credit card) to test this.

Now, refine that list for LinkedIn outreach. LinkedIn sequences work best when you speak to a narrow slice, not a wide bucket. In Origami, filter and segment your list by:

• Role specificity: Focus on titles that indicate hands-on AI decision-making—Head of AI/ML, Director of Data Science, Chief AI Officer, VP of Computational Biology. Avoid generic “IT Director” roles unless the company explicitly lists AI as their scope.
• Company sub-sector: Segment biotech (drug discovery), pharma (commercial analytics), medical devices (embedded AI), and payers/providers (clinical AI). The pain points differ.
• Company size: 200–1,000 employees often have a single AI leader who controls budget; 5,000+ might have a center of excellence you need to navigate. Tailor your message accordingly.
• Geography: US vs. EU changes the regulatory language (HIPAA vs. GDPR).

A “qualified” contact for this campaign is:

• Has AI in their title or explicitly leads AI/ML projects
• Works at a company that’s actively building or buying AI
• Has a public presence (posts, speaks, or is mentioned in press)

Once you’ve tagged and segmented, export nothing. Your list lives in Origami. You’ll send the LinkedIn sequence from the same dashboard.

---

Step 2: Create the LinkedIn Sequence (Two Ways)

Origami gives you two options to build your LinkedIn outreach sequence:

1. Paste your own templates: You write a 3-touch sequence (connection request, follow-up, final message) and paste them directly into the sequencer. Set delays between touches—most reps use Day 1, Day 3, and Day 7—and hit “Launch.” You control every word.

2. Let the agent write it: Ask Origami’s AI agent to generate a personalized 3-day LinkedIn sequence for all your leads. The agent drafts messages using each lead’s profile data—title, company, industry—so every message feels custom. You can tweak the output before sending.

For this guide, I’m giving you a proven sequence you can copy-paste and adapt. These messages were used to book meetings with AI leaders at top-20 pharma and health systems. The key is to sound like you understand their world, not like you’re selling a tool.

The Sequence (Copy This)

Audience context: You’re reaching out to AI leaders at healthcare organizations—pharma, biotech, medtech, hospitals—who are responsible for deploying or evaluating AI/ML models. Their daily challenges: regulatory compliance (FDA, HIPAA, GDPR), model validation, data silos, explainability, and the pressure to show ROI in a risk-averse industry.

---

Day 1: Connection Request + Note

Subject: AI-driven outcomes at {company}

“Hi {first_name}, I’m following {company}’s AI work—impressive. I work with healthcare AI leaders who are scaling models while keeping things audit-ready. Would be great to connect and stay in the loop on what you’re building. No pitch, just respect for the space.”

Why it works: Low ask, genuine interest, hints at the compliance angle without pushing a product. The mention of “audit-ready” resonates because every AI leader in regulated environments lives with one eye on the FDA.

---

Day 3: Follow-Up Message (Value Angle)

Subject: A thought on explainability

“Hi {first_name}, hope the week is going well. Quick thought: I’ve been hearing from pharma AI teams that explaining model decisions to clinical reviewers is the bottleneck after the PoC. Some are using structured evidence summaries to bridge the gap. Curious if that’s a challenge for {company}? Happy to share what I’ve seen—no strings.”

Why it works: Named a specific, universal pain point (explainability for clinical reviewers). It’s not a generic “I can help you” message. The offer to share insights feels helpful, not salesy.

---

Day 7: Final Message (Soft Close)

Subject: 15-min chat?

“Hi {first_name}, last nudge. I know {company} is pushing the envelope on {specific_AI_area}—and that comes with validation and integration headaches. I’d love to swap notes on how peers are handling it. Open to a 15-minute call next week? No formal presentation, just a chat.”

Why it works: Acknowledges their innovation while naming the cost of it. The “no formal presentation” softens the ask. The specificity of 15 minutes makes it low-risk.

---

You can plug these templates into Origami’s sequencer as-is. The platform will auto-personalize {first_name}, {company}, and any other merge fields it has enriched. For the final message, if you want to dynamically insert the AI area, you can pre-tag leads in your list (e.g., “Drug Discovery AI,” “Clinical NLP,” “Medical Imaging AI”) and use that tag as a merge field.

---

Step 3: Launch the Sequence Directly from Origami

This is where Origami saves you hours. You don’t need to export your list to a separate LinkedIn tool or manually invite prospects and copy-paste messages. Everything runs inside the platform where your list lives.

Here’s the flow:

1. Segment: In your Origami project, select the refined list (e.g., “Pharma AI Leaders – 200+ employees”).
2. Open the Sequencer: Click the LinkedIn Sequencer tab. You’ll see your templates. Assign the sequence you just created—or choose one generated by the AI agent.
3. Set delays: I use Day 1: connection request (sent immediately after launch), Day 3: first follow-up, Day 7: final message. You can set custom gaps. The system automatically respects LinkedIn’s safe limits.
4. Review personalizations: Origami shows a preview of each message with the actual lead data filled in. Spot-check a few to ensure quality.
5. Hit “Launch.” The sequencer starts sending connection requests and will drip the follow-ups on schedule.

Tracking & Context

Once live, the dashboard gives you open rates, click-throughs, and replies—all side-by-side with the enriched profile that Origami built. So when you see a reply, you can immediately see that they’re a VP of AI at a biotech using AWS and Databricks (from enrichment), and you’ll know exactly why you reached out.

Automatic un-enrollment: If a lead replies, they’re automatically pulled out of the sequence. No more sending a “just checking in” message after someone says “I’m interested.”

One important note: The LinkedIn sequencer is included on all paid plans. You pay only for the credits used to enrich leads—the sending itself is free. That means once you’ve built a list, you can sequence it without additional per-contact outreach costs.

---

Step 4: What Results to Expect (and When to Iterate)

For this audience—AI leaders in healthcare and life sciences—expect:

• Connection acceptance rate: 25–40% if your headline and profile are credible. These folks are selective, but they’re also eager to network with peers.
• Reply rate on follow-ups: 8–15% of accepted connections. That’s significantly higher than generic B2B outreach because the messaging addresses a specific, career-defining pain point (compliance, validation, ROI).
• Meeting conversion: Roughly 3–6% of the original list, meaning for every 100 targeted leads, you can book 3–6 meetings. In healthcare AI, that’s a strong outcome.

When to Tweak Messaging vs. the List

• Low connection acceptance: Your profile doesn’t signal healthcare AI credibility. Update your headline to something like “Helping healthcare AI teams scale without compliance debt.” If acceptance doesn’t improve, check that your list isn’t too broad. A generic AI leader at a hospital may ignore you, but a “Director of AI, Radiology” at a 500-bed academic medical center will self-select in.
• No replies after connecting: Your follow-up messages aren’t landing. Test tighter subject lines that reference a recent press release or a technical challenge (e.g., “reproducibility in imaging AI”). Also, make sure you haven’t sent the same sequence to a biotech founder as you would to a VP at Pfizer. Use segmentation.
• Replies but no meetings: Your final message is too safe. Add a specific angle based on their LinkedIn activity. For example, if they recently posted about FDA’s predetermined change control plans, reference that: “Saw your take on PCCPs—most teams I work with are struggling with that same piece. Happy to compare notes.”

Iterate in batches. After the first 50 sends, review the data inside Origami and adjust. You can duplicate your project, tweak the sequence, and run an A/B test without leaving the platform.

---